Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 3045-3052
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3045
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3045
Indicators | Time | Observation group (n = 40) | Control group (n = 40) | t | P value |
IgA | Before treatment | 2.81 ± 0.59 | 2.72 ± 0.55 | 0.706 | 0.483 |
After treatment | 2.46 ± 0.40a | 1.92 ± 0.41a | 5.962 | 0.000 | |
IgG | Before treatment | 10.57 ± 2.34 | 11.02 ± 2.28 | 0.871 | 0.386 |
After treatment | 7.64 ± 1.49a | 5.51 ± 1.21a | 7.018 | 0.000 | |
IgM | Before treatment | 1.02 ± 0.24 | 1.06 ± 0.22 | 0.777 | 0.440 |
After treatment | 0.71 ± 0.17a | 0.52 ± 0.13a | 5.615 | 0.000 |
- Citation: Yin Y, Yao Y, Li YJ, Zhao LL, Zhang Q. Effects of Tongluo Jiedu prescription on immune function and oxidative stress in patients with oral cancer. World J Clin Cases 2024; 12(17): 3045-3052
- URL: https://www.wjgnet.com/2307-8960/full/v12/i17/3045.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i17.3045